Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

NCT04908566 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Gastric Adenocarcinoma

Interventions

DRUG: PD-1 antibody combined with FOLFIRINOX regimen
DRUG: PD-1 antibody combined with SOX program

Sponsor

Tianjin Medical University Cancer Institute and Hospital